Cristina Llorente

Title(s)Assistant Adjunct Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Emailallorenteizquierdo@health.ucsd.edu
ORCID ORCID Icon0000-0001-8135-9186 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San Diego (UC San Diego), San Diego, USAAssistant ProfessorPresentMicrobiome and liver disease
    University of California San Diego (UC San Diego), San Diego, USA Assistant Project Scientist07/2019Microbiome and liver disease
    University of California San Diego (UC San Diego), San Diego, USAPostdoctoral Scholar-Employee01/2018Microbiome and liver disease
    Autonomous University of Madrid (UAM), Madrid, SpainPh.D.01/2013Biomedicine, Pre-doctoral fellow (FPI)
    Faculty of Medicine, Autonomous University of Madrid (UAM), Madrid, SpainMSs 09/2008Molecular Biomedicine
    Complutense University of Madrid (UCM), Madrid, SpainB.S.02/2008Biochemistry
    Collapse Awards and Honors
    NIAAA, NIH2023  - 20251R21AA030654-01A1 The role of intestinal gp130 in alcohol-associated liver disease
    UC San Diego MARC pilot grant, funded by the NIAMS, NIH2023  - 2024P30AR073761 Role of goblet cell associated antigen passages in autoimmune spondylarthritis
    NIAAA, NIH2022  - 20271R01AA029106-01A1 Goblet cells and intestinal immune response in alcohol-associated liver disease
    UC San Diego, USA, NIH2021  - 2022D34HP31027 Hispanic Center of Excellence (HCOE) Faculty Scholar and HCOE Award
    NIDDK–SDDRC and the Hellman Family Foundation2020  - 2021P30 DK120515 Jon I. Isenberg Fellowship Award
    UC San Diego, USA, NIH2020D34HP31027 Hispanic Center of Excellence (HCOE) Faculty Scholar and HCOE Award
    ALPD, UCS, NIAAA2019  - 2020P50AA011999 Pilot Project Intestinal stem-cell proliferation and differentiation in ALD
    American Association for the Study of Liver Diseases (AASLD), USA2018  - 2021 8998GA Pinnacle Research Award
    ALPD, UCS, NIAAA2018  - 2019 P50AA011999 Pilot ProjectPilot project grant by the Southern California Research Center for ALPD
    ALPD, UCS, NIAAA2017  - 2018P50AA011999 Pilot Project Pilot project grant by the Southern California Research Center for ALPD
    Ministry of Economy and Competitiveness (MINECO), Spain2012Pre-doctoral Internship fellowship (Olefsky's lab)
    Ministry of Economy and Competitiveness (MINECO), Spain2008  - 2013Pre-doctoral fellowship (FPI)

    Collapse Overview 
    Collapse Overview
    The major focus of my lab is to decipher the molecular mechanisms involved in the progression of liver diseases to discover therapies and molecular targets to alleviate it. Our current research is focused on uncovering the intricacies of the gut microbiome-host immune system interactions during liver diseases. Our work published in Nature Communications (2023 Impact Factor = 14.7) demonstrated that gastric acid suppression contributes to alcohol-associated liver disease in mice and humans. This is mediated by the overgrowth of intestinal Enterococcus and its translocation to the liver. During my appointment as Assistant Professor in August 2019, our efforts to study the role of Enterococcus in alcohol-related liver disease resulted in a co-first authorship in the prestigious journal Nature (2023 Impact Factor = 50.5). Briefly, we found that alcoholic hepatitis in humans is associated with the presence of a pore-forming toxin called cytolysin produced by Enterococcus faecalis. Cytolytic Enterococcus faecalis was determined as a novel predictor of mortality in alcoholic hepatitis patients. We also used a novel precision approach using bacteriophages as a therapeutic strategy to reduce ethanol-induced liver injury in mice. Among other efforts, we also assessed the contribution of intestinal α1-2-fucosylation to obesity and steatohepatitis in mice. This work was published as a co-first author in Cellular and Molecular Gastroenterology and Hepatology (2023 Impact Factor = 7.1). Currently, my research program is centered on the investigation of the role of the neuro-immune regulation mediated by small intestinal goblet cell-associated antigen passages (GAPs) and their crucial role in maintaining intestinal homeostasis, with a specific focus on preventing bacterial translocation and the development of alcohol-associated liver disease. Our research has led to the development of an innovative intervention aimed at preventing alcohol-related liver disease. We have submitted a patent application for the mAChR4 agonist as a treatment for alcohol-associated liver disease.
    I have contributed to 40 accepted publications in the field of the intestinal microbiome, mycobiome, and liver disease and published first-author manuscripts in high-impact journals such as Nature (2020 Impact Factor = 49.962), Nature Communications (2020 Impact Factor = 14.919), Cellular and Molecular Gastroenterology and Hepatology (2020 Impact Factor = 9.225) and co-authored in journals such as Journal of Hepatology (2020 Impact Factor = 25.083), Cell Host and Microbe journal (2020 Impact Factor = 21.023), Hepatology (2020 Impact Factor = 17.425) and Journal of Clinical Investigation (2020 Impact Factor = 14.808) among others.
    My research program is designed with a singular focus: delving into the complexities of the intestinal microbiome, the dynamics of intestinal homeostasis, in particular, the intricate interactions with the mucosal immune system, and its implications in the pathogenesis of liver disease. My research is translational, and my program aims to find cures for liver diseases. Liver disease, much like numerous other health conditions, can disproportionately impact historically marginalized or underrepresented communities.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases. eGastroenterology. 2024 Oct; 2(3). Tonetti FR, Eguileor A, Llorente C. PMID: 39524932; PMCID: PMC11542612.
      View in: PubMed   Mentions:
    2. IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis. Cell Metab. 2024 Oct 01; 36(10):2341-2354.e6. Zhang P, Liu J, Lee A, Tsaur I, Ohira M, Duong V, Vo N, Watari K, Su H, Kim JY, Gu L, Zhu M, Shalapour S, Hosseini M, Bandyopadhyay G, Zeng S, Llorente C, Zhao HN, Lamichhane S, Mohan S, Dorrestein PC, Olefsky JM, Schnabl B, Soroosh P, Karin M. PMID: 39317186.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. Commentary on the gut microbiome in alcohol use disorder and alcohol-associated liver disease. Alcohol Clin Exp Res (Hoboken). 2024 Aug; 48(8):1466-1468. Llorente C. PMID: 38825713; PMCID: PMC11305903.
      View in: PubMed   Mentions:    Fields:    
    4. The Imperative for Innovative Enteric Nervous System-Intestinal Organoid Co-Culture Models: Transforming GI Disease Modeling and Treatment. Cells. 2024 May 10; 13(10). Llorente C. PMID: 38786042; PMCID: PMC11119846.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Isolation of Myenteric and Submucosal Plexus from Mouse Gastrointestinal Tract and Subsequent Co-Culture with Small Intestinal Organoids. Cells. 2024 May 10; 13(10). Llorente C. PMID: 38786037; PMCID: PMC11120043.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    6. Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease. Hepatology. 2024 May 01. Raya Tonetti F, Eguileor A, Mrdjen M, Pathak V, Travers J, Nagy LE, Llorente C. PMID: 38691396.
      View in: PubMed   Mentions: 1     Fields:    
    7. The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine. Life Sci Alliance. 2023 11; 6(11). Hernandez JE, Llorente C, Ma S, Miyamoto KT, Sinha S, Steele S, Xiao Z, Lai CJ, Zuniga EI, Ghosh P, Schnabl B, Huang WJM. PMID: 37666668; PMCID: PMC10477432.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    8. Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice. Alcohol Clin Exp Res (Hoboken). 2023 May; 47(5):856-867. Kouno T, Zeng S, Wang Y, Duan Y, Lang S, Gao B, Hartmann P, Cabré N, Llorente C, Galbert C, Emond P, Sokol H, James M, Chao CC, Gao JR, Perreault M, Hava DL, Schnabl B. PMID: 36871955; PMCID: PMC10795770.
      View in: PubMed   Mentions: 8     Fields:    
    9. IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice. Hepatology. 2023 07 01; 78(1):295-306. Cabré N, Hartmann P, Llorente C, Kouno T, Wang Y, Zeng S, Kim HY, Zhang X, Kisseleva T, Iyer S, Kudumala S, Schnabl B. PMID: 36811393; PMCID: PMC10293100.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    10. Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease. Dig Dis Sci. 2023 07; 68(7):3059-3069. Hsu CL, Wang Y, Duan Y, Chu H, Hartmann P, Llorente C, Zhou R, Schnabl B. PMID: 36807831; PMCID: PMC10313731.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    11. Malassezia restricta promotes alcohol-induced liver injury. Hepatol Commun. 2023 02 01; 7(2):e0029. Zeng S, Hartmann P, Park M, Duan Y, Lang S, Llorente C, Wang Y, Cabré N, Fouts DE, Bacher P, Jung WH, Stärkel P, Schnabl B. PMID: 36706195; PMCID: PMC9988279.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    12. Intestinal dendritic cells, gatekeepers preventing ethanol-induced liver disease. Hepatology. 2023 09 01; 78(3):697-701. Llorente C, Rungratanawanich W, Liangpunsakul S. PMID: 36930746; PMCID: PMC10315410.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. Synovial tissue metabolomic profiling reveal biomarkers of synovial inflammation in patients with osteoarthritis. Osteoarthr Cartil Open. 2022 Sep; 4(3):100295. Murillo-Saich JD, Coras R, Meyer R, Llorente C, Lane NE, Guma M. PMID: 36474936; PMCID: PMC9718344.
      View in: PubMed   Mentions: 3  
    14. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun. 2021 12 09; 12(1):7172. Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, Hosseini M, Kisseleva T, Brenner DA, Bataller R, Ramachandran P, Karin M, Fu W, Schnabl B. PMID: 34887405; PMCID: PMC8660815.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    15. Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. Cells. 2021 06 14; 10(6). Cabré N, Duan Y, Llorente C, Conrad M, Stern P, Yamashita D, Schnabl B. PMID: 34198609; PMCID: PMC8232222.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    16. Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. Cell Mol Gastroenterol Hepatol. 2021; 12(1):293-320. Zhou R, Llorente C, Cao J, Zaramela LS, Zeng S, Gao B, Li SZ, Welch RD, Huang FQ, Qi LW, Pan C, Huang Y, Zhou P, Beussen I, Zhang Y, Bryam G, Fiehn O, Wang L, Liu EH, Yu RT, Downes M, Evans RM, Goglin K, Fouts DE, Brenner DA, Bode L, Fan X, Zengler K, Schnabl B. PMID: 33631374; PMCID: PMC8166943.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    17. A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease. Int J Biol Sci. 2021; 17(1):307-327. Bruellman R, Llorente C. PMID: 33390852; PMCID: PMC7757023.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    18. Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. Alcohol Clin Exp Res. 2020 09; 44(9):1842-1851. Zhou R, Llorente C, Cao J, Gao B, Duan Y, Jiang L, Wang Y, Kumar V, Stärkel P, Bode L, Fan X, Schnabl B. PMID: 32628772; PMCID: PMC7808344.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    19. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019 11; 575(7783):505-511. Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, Miyamoto Y, Ly M, Gao B, Sun W, Kiesel R, Hutmacher F, Lee S, Ventura-Cots M, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Tu XM, Eckmann L, van der Donk WA, Young R, Lawley TD, Stärkel P, Pride D, Fouts DE, Schnabl B. PMID: 31723265; PMCID: PMC6872939.
      View in: PubMed   Mentions: 325     Fields:    Translation:HumansAnimalsCells
    20. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol. 2020 03; 72(3):391-400. Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, Vargas V, Tu XM, Yang L, Hou X, Hube B, Stärkel P, Schnabl B. PMID: 31606552; PMCID: PMC7031049.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    21. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019 07 11; 129(10):4091-4109. Calvente CJ, Tameda M, Johnson CD, Del Pilar H, Lin YC, Adronikou N, De Mollerat Du Jeu X, Llorente C, Boyer J, Feldstein AE. PMID: 31295147; PMCID: PMC6763256.
      View in: PubMed   Mentions: 101     Fields:    Translation:AnimalsCells
    22. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018 06; 67(6):2150-2166. Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. PMID: 29159825; PMCID: PMC5962369.
      View in: PubMed   Mentions: 125     Fields:    Translation:Animals
    23. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology. 2018 05; 67(5):1737-1753. Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H. PMID: 29108122; PMCID: PMC5906140.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansAnimalsCells
    24. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017 12 12; 8(1):2137. Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. PMID: 29233961; PMCID: PMC5727102.
      View in: PubMed   Mentions: 9     Fields:    
    25. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017 10 16; 8(1):837. Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. PMID: 29038503; PMCID: PMC5643518.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    26. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017 Jun 30; 127(7):2829-2841. Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, Kisseleva T, Torralba MG, Moncera K, Beeri K, Chen CS, Freese K, Hellerbrand C, Lee SM, Hoffman HM, Mehal WZ, Garcia-Tsao G, Mutlu EA, Keshavarzian A, Brown GD, Ho SB, Bataller R, Stärkel P, Fouts DE, Schnabl B. PMID: 28530644; PMCID: PMC5490775.
      View in: PubMed   Mentions: 225     Fields:    Translation:HumansAnimalsCells
    27. Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice. Alcohol Clin Exp Res. 2016 12; 40(12):2604-2613. Inamine T, Yang AM, Wang L, Lee KC, Llorente C, Schnabl B. PMID: 27739086; PMCID: PMC5133156.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    28. Fast-Track Clearance of Bacteria from the Liver. Cell Host Microbe. 2016 07 13; 20(1):1-2. Llorente C, Schnabl B. PMID: 27414492.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    29. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. Cell Host Microbe. 2016 Feb 10; 19(2):227-39. Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho SB, Brenner DA, Hooper LV, Schnabl B. PMID: 26867181; PMCID: PMC4786170.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansAnimalsCells
    30. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 01; 310(5):G310-22. Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B. PMID: 26702135; PMCID: PMC4773827.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    31. The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol. 2015 May 01; 1(3):275-284. Llorente C, Schnabl B. PMID: 26090511; PMCID: PMC4467911.
      View in: PubMed   Mentions: 80     Fields:    
    32. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab. 2015 May; 4(5):378-91. Mayoral R, Osborn O, McNelis J, Johnson AM, Oh DY, Izquierdo CL, Chung H, Li P, Traves PG, Bandyopadhyay G, Pessentheiner AR, Ofrecio JM, Cook JR, Qiang L, Accili D, Olefsky JM. PMID: 25973386; PMCID: PMC4421024.
      View in: PubMed   Mentions: 80     Fields:    
    33. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015 Jun; 421:44-53. Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. PMID: 25595554; PMCID: PMC4451427.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansAnimalsCells
    34. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. Int J Biochem Cell Biol. 2013 Nov; 45(11):2501-11. Castro-Sánchez L, Agra N, Llorente Izquierdo C, Motiño O, Casado M, Boscá L, Martín-Sanz P. PMID: 23954207.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    35. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression. Prostaglandins Other Lipid Mediat. 2013 Oct; 106:106-15. Llorente-Izquierdo C, Mayoral R, Cucarella C, Grau C, Alvarez MS, Flores JM, García-Palencia P, Agra N, Castro-Sánchez L, Boscá L, Martín-Sanz P, Casado M. PMID: 23579063.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    36. Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells. PLoS One. 2012; 7(11):e50935. Agra Andrieu N, Motiño O, Mayoral R, Llorente Izquierdo C, Fernández-Alvarez A, Boscá L, Casado M, Martín-Sanz P. PMID: 23226427; PMCID: PMC3511388.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    37. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma. Oncogenesis. 2012 Jul 09; 1:e23. Fernández-Alvarez A, Llorente-Izquierdo C, Mayoral R, Agra N, Boscá L, Casado M, Martín-Sanz P. PMID: 23552739; PMCID: PMC3412654.
      View in: PubMed   Mentions: 11  
    38. Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis. Am J Pathol. 2011 Mar; 178(3):1361-73. Llorente Izquierdo C, Mayoral R, Flores JM, García-Palencia P, Cucarella C, Boscá L, Casado M, Martín-Sanz P. PMID: 21356386; PMCID: PMC3069875.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    39. Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration. J Biol Chem. 2010 Feb 05; 285(6):3633-3642. Mayoral R, Valverde ÁM, Llorente Izquierdo C, González-Rodríguez Á, Boscá L, Martín-Sanz P. PMID: 19966340; PMCID: PMC2823504.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    40. Antibodies in urine of chimpanzees with chronic adenoviral viruria. Infect Immun. 1978 Aug; 21(2):458-61. Ashner LV, Asher DM, Shah KV, Amyx HL, Gibbs CJ, Gajdusek DC. PMID: 211084; PMCID: PMC422018.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    Cristina's Networks
    Concepts (185)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (29)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California